Clinical Trial Update: MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 multicentric intracerebral grafting study for Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED